NVS logo

Novartis AG (NVS) Revenue

Annual revenue:

$51.72B+$5.06B(+10.85%)
December 31, 2024

Summary

  • As of today (August 2, 2025), NVS annual revenue is $51.72 billion, with the most recent change of +$5.06 billion (+10.85%) on December 31, 2024.
  • During the last 3 years, NVS annual revenue has risen by +$7.75 billion (+17.62%).
  • NVS annual revenue is now -12.89% below its all-time high of $59.38 billion, reached on December 31, 2011.

Performance

1-year change

+10.85%

3-year change

+17.62%

5-year change

+6.26%

15-year change

+19.16%

NVS Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

98.17%
NVS annual revenue is higher than 98.17% of companies in Healthcare sector

Analysts estimate

$54.94B
NVS annual revenue is currently -5.86% lower than the consensus analysts' forecast

Range

All-time high

$59.38B
NVS annual revenue is currently -12.89% below its historical high of $59.38 billion

3-year low

$43.46B
NVS annual revenue is currently +19.01% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
NVS previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
NVS next annual earnings announcement has not yet been scheduled

OtherNVSincome statement metrics

Annual EPS

$5.87
NVS annual earnings per share is $5.87

annual net income

$11.94B
NVS annual net profit is $11.94 billion

annual operating profit

$14.54B
NVS annual operating income is $14.54 billion

Annual gross profit

$38.90B
NVS annual gross profit is $38.90 billion

Quarterly revenue:

$14.84B+$1.22B(+8.93%)
June 30, 2025

Summary

  • As of today (August 2, 2025), NVS quarterly revenue is $14.84 billion, with the most recent change of +$1.22 billion (+8.93%) on June 30, 2025.
  • Over the past year, NVS quarterly revenue has increased by +$1.96 billion (+15.26%).
  • NVS quarterly revenue is now -1.90% below its all-time high of $15.12 billion, reached on June 30, 2011.

Performance

3-month change

+8.93%

1-year change

+15.26%

3-year change

+13.38%

5-year change

+27.65%

NVS Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

98.19%
NVS quarterly revenue is higher than 98.19% of companies in Healthcare sector

Analysts estimate

$13.69B
NVS quarterly revenue is currently +8.38% higher than the consensus analysts' forecast

Range

All-time high

$15.12B
NVS quarterly revenue is currently -1.90% below its historical high of $15.12 billion

3-year low

$10.78B
NVS quarterly revenue is currently +37.59% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
NVS previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 28, 2025
NVS next earnings announcement is scheduled for Oct 28, 2025

OtherNVSincome statement metrics

quarterly gross profit

$11.51B
NVS quarterly gross profit is $11.51 billion

quarterly operating profit

$4.86B
NVS quarterly operating income is $4.86 billion

quarterly net income

$4.04B
NVS quarterly net profit is $4.04 billion

Quarterly EPS

$2.06
NVS quarterly earnings per share is $2.06

TTM revenue:

$55.19B+$1.96B(+3.69%)
June 30, 2025

Summary

  • As of today (August 2, 2025), NVS TTM revenue is $55.19 billion, with the most recent change of +$1.96 billion (+3.69%) on June 30, 2025.
  • Over the past year, NVS TTM revenue has increased by +$6.33 billion (+12.95%).
  • NVS TTM revenue is now -7.06% below its all-time high of $59.38 billion, reached on December 31, 2011.

Performance

3-month change

+3.69%

1-year change

+12.95%

3-year change

+25.75%

5-year change

+11.42%

NVS TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

97.93%
NVS TTM revenue is higher than 97.93% of companies in Healthcare sector

Analysts estimate

$55.70B
NVS TTM revenue is currently -0.93% lower than the consensus analysts' forecast

Range

All-time high

$59.38B
NVS TTM revenue is currently -7.06% below its historical high of $59.38 billion

3-year low

$41.30B
NVS TTM revenue is currently +33.62% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
NVS previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 28, 2025
NVS next earnings announcement is scheduled for Oct 28, 2025

OtherNVSincome statement metrics

TTM gross profit

$42.08B
NVS TTM gross profit is $42.08 billion

TTM operating profit

$16.68B
NVS TTM operating income is $16.68 billion

TTM net income

$13.65B
NVS TTM net profit is $13.65 billion

TTM EPS

$6.86
NVS TTM earnings per share is $6.86

NVS Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+10.8%+15.3%+12.9%
3 y3 years+17.6%+13.4%+25.8%
5 y5 years+6.3%+27.6%+11.4%

NVS Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+19.0%at high+37.6%at high+33.6%
5 y5-yearat high+19.0%at high+221.2%at high+33.6%
alltimeall time-12.9%+175.7%-1.9%+246.8%-7.1%+868.7%

NVS Revenue History

DateAnnualQuarterlyTTM
Jun 2025
-
$14.84B(+8.9%)
$55.19B(+3.7%)
Mar 2025
-
$13.62B(+0.5%)
$53.22B(+2.9%)
Dec 2024
$51.72B(+10.8%)
$13.56B(+2.9%)
$51.72B(+3.6%)
Sep 2024
-
$13.17B(+2.3%)
$49.94B(+2.2%)
Jun 2024
-
$12.87B(+6.2%)
$48.86B(+2.4%)
Mar 2024
-
$12.12B(+2.9%)
$47.73B(+2.3%)
Dec 2023
$46.66B(+7.4%)
$11.78B(-2.6%)
$46.66B(+1.8%)
Sep 2023
-
$12.09B(+3.0%)
$45.85B(+2.9%)
Jun 2023
-
$11.74B(+6.3%)
$44.54B(-2.9%)
Mar 2023
-
$11.05B(+0.7%)
$45.88B(-3.7%)
Dec 2022
$43.46B(-1.2%)
$10.97B(+1.7%)
$47.65B(+15.4%)
Sep 2022
-
$10.78B(-17.6%)
$41.30B(-5.9%)
Jun 2022
-
$13.09B(+2.1%)
$43.88B(-0.5%)
Mar 2022
-
$12.81B(+177.4%)
$44.09B(+0.3%)
Dec 2021
$43.97B(-11.9%)
$4.62B(-65.4%)
$43.97B(-16.1%)
Sep 2021
-
$13.37B(+0.5%)
$52.38B(+1.6%)
Jun 2021
-
$13.29B(+4.7%)
$51.56B(+3.4%)
Mar 2021
-
$12.69B(-2.6%)
$49.88B(-0.0%)
Dec 2020
$49.90B(+2.5%)
$13.03B(+3.9%)
$49.90B(+0.6%)
Sep 2020
-
$12.54B(+7.9%)
$49.58B(+0.1%)
Jun 2020
-
$11.62B(-8.5%)
$49.53B(-0.8%)
Mar 2020
-
$12.71B(-0.1%)
$49.93B(+2.6%)
Dec 2019
$48.68B(+5.6%)
$12.72B(+1.9%)
$48.68B(+1.7%)
Sep 2019
-
$12.48B(+3.8%)
$47.86B(+2.3%)
Jun 2019
-
$12.02B(+5.0%)
$46.76B(+0.8%)
Mar 2019
-
$11.46B(-3.7%)
$46.39B(+0.6%)
Dec 2018
$46.10B(+6.2%)
$11.90B(+4.5%)
$46.10B(+13.4%)
Sep 2018
-
$11.39B(-2.3%)
$40.63B(-3.1%)
Jun 2018
-
$11.65B(+4.4%)
$41.94B(-2.0%)
Mar 2018
-
$11.16B(+73.5%)
$42.78B(-1.4%)
Dec 2017
$43.40B(-12.2%)
$6.43B(-49.3%)
$43.40B(-12.5%)
Sep 2017
-
$12.69B(+1.6%)
$49.58B(+0.7%)
Jun 2017
-
$12.49B(+6.0%)
$49.23B(-0.4%)
Mar 2017
-
$11.79B(-6.5%)
$49.41B(-0.1%)
Dec 2016
$49.44B(-1.9%)
$12.61B(+2.1%)
$49.44B(-0.4%)
Sep 2016
-
$12.34B(-2.7%)
$49.63B(-0.3%)
Jun 2016
-
$12.68B(+7.4%)
$49.78B(-0.4%)
Mar 2016
-
$11.81B(-7.8%)
$49.99B(-0.8%)
Dec 2015
$50.39B(-6.1%)
$12.80B(+2.6%)
$50.39B(-1.1%)
Sep 2015
-
$12.48B(-3.2%)
$50.94B(-1.6%)
Jun 2015
-
$12.90B(+5.7%)
$51.75B(-2.0%)
Mar 2015
-
$12.20B(-8.6%)
$52.80B(-1.5%)
Dec 2014
$53.63B(+1.7%)
$13.35B(+0.4%)
$53.63B(-0.5%)
Sep 2014
-
$13.30B(-4.7%)
$53.91B(+0.7%)
Jun 2014
-
$13.95B(+7.0%)
$53.51B(+1.3%)
Mar 2014
-
$13.03B(-4.4%)
$52.84B(-2.2%)
Dec 2013
$52.72B(+1.4%)
$13.63B(+5.6%)
$54.02B(+8.3%)
Sep 2013
-
$12.91B(-2.8%)
$49.87B(-2.2%)
Jun 2013
-
$13.28B(-6.5%)
$51.00B(-2.4%)
Mar 2013
-
$14.21B(+49.9%)
$52.26B(+0.6%)
Dec 2012
$51.97B
$9.48B(-32.5%)
$51.97B(-9.6%)
Sep 2012
-
$14.04B(-3.5%)
$57.49B(-1.7%)
DateAnnualQuarterlyTTM
Jun 2012
-
$14.54B(+4.5%)
$58.48B(-1.0%)
Mar 2012
-
$13.91B(-7.2%)
$59.07B(-0.5%)
Dec 2011
$59.38B(+15.2%)
$15.00B(-0.3%)
$59.38B(+0.9%)
Sep 2011
-
$15.03B(-0.6%)
$58.84B(+3.9%)
Jun 2011
-
$15.12B(+6.3%)
$56.63B(+6.0%)
Mar 2011
-
$14.22B(-1.7%)
$53.43B(+3.6%)
Dec 2010
$51.56B(+14.3%)
$14.46B(+12.8%)
$51.56B(+2.6%)
Sep 2010
-
$12.82B(+7.5%)
$50.24B(+3.1%)
Jun 2010
-
$11.92B(-3.5%)
$48.71B(+2.5%)
Mar 2010
-
$12.36B(-6.0%)
$47.53B(+5.4%)
Dec 2009
$45.10B(+5.9%)
$13.14B(+16.4%)
$45.10B(+6.6%)
Sep 2009
-
$11.29B(+5.1%)
$42.31B(+0.6%)
Jun 2009
-
$10.74B(+8.2%)
$42.05B(-0.6%)
Mar 2009
-
$9.93B(-4.1%)
$42.29B(-0.7%)
Dec 2008
$42.58B(+9.3%)
$10.35B(-6.2%)
$42.58B(+0.4%)
Sep 2008
-
$11.03B(+0.4%)
$42.41B(+2.9%)
Jun 2008
-
$10.99B(+7.6%)
$41.20B(+4.0%)
Mar 2008
-
$10.22B(+0.4%)
$39.60B(+2.2%)
Dec 2007
$38.95B(+10.9%)
$10.17B(+3.6%)
$38.76B(+1.4%)
Sep 2007
-
$9.82B(+4.4%)
$38.25B(+2.1%)
Jun 2007
-
$9.40B(+0.3%)
$37.45B(+2.4%)
Mar 2007
-
$9.37B(-2.9%)
$36.56B(+3.5%)
Dec 2006
$35.10B(+18.0%)
$9.65B(+7.0%)
$35.34B(+11.6%)
Sep 2006
-
$9.02B(+6.1%)
$31.66B(+1.7%)
Jun 2006
-
$8.51B(+4.4%)
$31.13B(+2.1%)
Mar 2006
-
$8.15B(+36.3%)
$30.49B(+2.7%)
Dec 2005
$29.75B(+9.1%)
$5.98B(-29.6%)
$29.68B(-2.1%)
Sep 2005
-
$8.49B(+7.9%)
$30.31B(+5.0%)
Jun 2005
-
$7.87B(+7.2%)
$28.88B(+3.2%)
Mar 2005
-
$7.34B(+11.1%)
$27.98B(+2.6%)
Dec 2004
$27.28B(+9.4%)
$6.61B(-6.4%)
$27.28B(-0.7%)
Sep 2004
-
$7.06B(+1.2%)
$27.46B(+3.2%)
Jun 2004
-
$6.97B(+5.0%)
$26.62B(+3.0%)
Mar 2004
-
$6.64B(-2.3%)
$25.85B(+3.7%)
Dec 2003
$24.93B(+19.4%)
$6.80B(+9.4%)
$24.93B(+5.3%)
Sep 2003
-
$6.21B(+0.1%)
$23.66B(+5.1%)
Jun 2003
-
$6.20B(+8.4%)
$22.51B(+2.8%)
Mar 2003
-
$5.72B(+3.4%)
$21.91B(+4.1%)
Dec 2002
$20.88B(+11.3%)
$5.53B(+9.3%)
$21.05B(+4.8%)
Sep 2002
-
$5.06B(-9.6%)
$20.08B(-2.5%)
Jun 2002
-
$5.60B(+15.2%)
$20.60B(+6.7%)
Mar 2002
-
$4.86B(+6.4%)
$19.31B(+2.2%)
Dec 2001
$18.76B(-15.4%)
$4.57B(-18.1%)
$18.89B(-8.5%)
Sep 2001
-
$5.58B(+29.3%)
$20.64B(+3.5%)
Jun 2001
-
$4.31B(-2.9%)
$19.95B(+0.2%)
Mar 2001
-
$4.44B(-29.7%)
$19.91B(-5.9%)
Dec 2000
$22.18B(+8.8%)
$6.31B(+29.4%)
$21.17B(+42.5%)
Sep 2000
-
$4.88B(+14.1%)
$14.86B(+48.9%)
Jun 2000
-
$4.28B(-24.9%)
$9.97B(+75.1%)
Mar 2000
-
$5.70B
$5.70B
Dec 1999
$20.39B(-11.5%)
-
-
Dec 1998
$23.04B
-
-

FAQ

  • What is Novartis AG annual revenue?
  • What is the all time high annual revenue for Novartis AG?
  • What is Novartis AG annual revenue year-on-year change?
  • What is Novartis AG quarterly revenue?
  • What is the all time high quarterly revenue for Novartis AG?
  • What is Novartis AG quarterly revenue year-on-year change?
  • What is Novartis AG TTM revenue?
  • What is the all time high TTM revenue for Novartis AG?
  • What is Novartis AG TTM revenue year-on-year change?

What is Novartis AG annual revenue?

The current annual revenue of NVS is $51.72B

What is the all time high annual revenue for Novartis AG?

Novartis AG all-time high annual revenue is $59.38B

What is Novartis AG annual revenue year-on-year change?

Over the past year, NVS annual revenue has changed by +$5.06B (+10.85%)

What is Novartis AG quarterly revenue?

The current quarterly revenue of NVS is $14.84B

What is the all time high quarterly revenue for Novartis AG?

Novartis AG all-time high quarterly revenue is $15.12B

What is Novartis AG quarterly revenue year-on-year change?

Over the past year, NVS quarterly revenue has changed by +$1.96B (+15.26%)

What is Novartis AG TTM revenue?

The current TTM revenue of NVS is $55.19B

What is the all time high TTM revenue for Novartis AG?

Novartis AG all-time high TTM revenue is $59.38B

What is Novartis AG TTM revenue year-on-year change?

Over the past year, NVS TTM revenue has changed by +$6.33B (+12.95%)
On this page